Company Filing History:
Years Active: 2020
Title: Anthony Brureau: Innovator in Alzheimer's Disease Therapies
Introduction
Anthony Brureau is a notable inventor based in Chilly Mazarin, France. He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease. His innovative approach focuses on combinatorial therapies that aim to improve patient outcomes.
Latest Patents
Anthony Brureau holds a patent for "Idalopirdine-based combinatorial therapies of Alzheimer's disease." This invention relates to therapies and methods for treating Alzheimer's disease or related disorders using idalopirdine, baclofen, and acamprosate. Notably, idalopirdine is administered in suboptimal doses to enhance its effectiveness.
Career Highlights
Brureau is associated with Pharnext, a company dedicated to developing innovative treatments for neurodegenerative diseases. His work at Pharnext has positioned him as a key player in the pharmaceutical industry, particularly in the realm of Alzheimer's research.
Collaborations
Throughout his career, Anthony has collaborated with esteemed colleagues such as Daniel Cohen and Serguei Nabirochkin. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Anthony Brureau's contributions to Alzheimer's disease therapies highlight his commitment to innovation in medicine. His patent and work at Pharnext reflect a dedication to improving the lives of those affected by neurodegenerative disorders.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.